NCT02487693View on ClinicalTrials.gov

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2038

Study Completion Date

June 30, 2040

Conditions
Ovarian Carcinoma
Interventions
PROCEDURE

Radiofrequency ablation

Radiofrequency ablation is performed percutaneously under CT/US guidance

BIOLOGICAL

Cytokine-induced killer cells

The patients received autologous cytokine-induced killer cells transfusion one week after RFA treatment.

All Listed Sponsors
lead

The First People's Hospital of Changzhou

OTHER